Clinical Trial Update: RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Rituximab to placebo in polyneuropathy associated with anti-MAG IgM monoclonal gammopathy has completed. The document indicates the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polyneuropathy

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Polyneuropathy | Phase 3 | Status: COMPLETED